Cagent Vascular

Wayne, United States

Cagent Vascular develops a serration technology for improving the treatment of cardiovascular disease.

May 2026

Series D

Top Investors

U.S. Venture PartnersTrinity CapitalBen Franklin Technology Partners of Southeastern PennsylvaniaBen Franklin Technology PartnersAstoria Health Investors

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cagent Vascular

Who are Cagent Vascular's investors?

Cagent Vascular's investors include U.S. Venture Partners, Trinity Capital, Ben Franklin Technology Partners of Southeastern Pennsylvania, Ben Franklin Technology Partners, Astoria Health Investors.

Where is Cagent Vascular headquartered?

Cagent Vascular is headquartered in Wayne, United States.

What does Cagent Vascular do?

Cagent Vascular develops a serration technology for improving the treatment of cardiovascular disease.

What stage is Cagent Vascular at?

Cagent Vascular is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 19, 2026.

MLA

"Cagent Vascular — Funding & Investors." VCBacked, May 19, 2026, https://www.vcbacked.co/company/cagent-vascular. Accessed June 17, 2026.

APA

VCBacked. (2026). Cagent Vascular — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/cagent-vascular

Wikipedia (cite web)

{{cite web |title=Cagent Vascular — Funding & Investors |url=https://www.vcbacked.co/company/cagent-vascular |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 19, 2026.